BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8386628)

  • 1. Tissue-type plasminogen activator mutants imitating urokinase in the peptide link between kringle and protease domains and at selected sites within the protease domain.
    Hinzmann B; Wernicke D; Pfeifer M; Zacharias U; Fischer B; Eisenmenger F; Will H
    Eur J Biochem; 1993 Apr; 213(1):437-43. PubMed ID: 8386628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH; Nieuwenbroek NM; Verheijen JH
    Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
    Novokhatny V; Medved L; Lijnen HR; Ingham K
    J Biol Chem; 1995 Apr; 270(15):8680-5. PubMed ID: 7721771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human tissue-type plasminogen activator variants with amino acid mutations in the kringle 1 domain.
    Ikenaka Y; Yajima K; Yahara H; Maruyama H; Matsumoto K; Okada K; Ueshima S; Matsuo O
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):381-7. PubMed ID: 1330023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
    Boutaud A; Castellino FJ
    Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kringle glycosylation in a modified human tissue plasminogen activator improves functional properties.
    Berg DT; Burck PJ; Berg DH; Grinnell BW
    Blood; 1993 Mar; 81(5):1312-22. PubMed ID: 8382971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural determinants of the noncatalytic chain of tissue-type plasminogen activator that modulate its association rate with plasminogen activator inhibitor-1.
    de Serrano VS; Castellino FJ
    J Biol Chem; 1990 Jun; 265(18):10473-8. PubMed ID: 2113057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tissue plasminogen activator finger domain confers fibrin-dependent enhancement of catalytic activity to single-chain urokinase-type plasminogen activator.
    Lubin IM; Caban R; Runge MS
    J Biol Chem; 1993 Mar; 268(8):5550-6. PubMed ID: 8449917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of tissue-type plasminogen activator-specific plasminogen activator inhibitor-1 mutants. Evidence that second sites of interaction contribute to target specificity.
    Sherman PM; Lawrence DA; Verhamme IM; Paielli D; Shore JD; Ginsburg D
    J Biol Chem; 1995 Apr; 270(16):9301-6. PubMed ID: 7721851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure basis of the poor fibrin specificity of urokinase (II)--The inhibition of urokinase A chain 149-157 on the fibrin stimulated activation of plasminogen by tissue type plasminogen activator.
    Song A; Liu JN; Yu RR; Cui DF; Zhou TM; Cui HR; Zhu DX
    Sci China B; 1992 Aug; 35(8):966-73. PubMed ID: 1338753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High resolution analysis of functional determinants on human tissue-type plasminogen activator.
    Bennett WF; Paoni NF; Keyt BA; Botstein D; Jones AJ; Presta L; Wurm FM; Zoller MJ
    J Biol Chem; 1991 Mar; 266(8):5191-201. PubMed ID: 1900516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenesis at Pro309 of single-chain urokinase-type plasminogen activator alters its catalytic properties.
    Sun Z; Liu JN
    Proteins; 2005 Dec; 61(4):870-7. PubMed ID: 16231330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
    Bugge TH; Flick MJ; Danton MJ; Daugherty CC; Romer J; Dano K; Carmeliet P; Collen D; Degen JL
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5899-904. PubMed ID: 8650190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and expression of hybrid plasminogen activators prepared from tissue-type plasminogen activator and urokinase-type plasminogen activator genes.
    Lee SG; Kalyan N; Wilhelm J; Hum WT; Rappaport R; Cheng SM; Dheer S; Urbano C; Hartzell RW; Ronchetti-Blume M
    J Biol Chem; 1988 Feb; 263(6):2917-24. PubMed ID: 3125172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The plasminogen activator inhibitor-1 binding site in the kringle-2 domain of tissue-type plasminogen activator.
    Kaneko M; Mimuro J; Matsuda M; Sakata Y
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1160-6. PubMed ID: 1908232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins.
    de Vries C; Veerman H; Blasi F; Pannekoek H
    Biochemistry; 1988 Apr; 27(7):2565-72. PubMed ID: 3132969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and expression of a hybrid plasminogen activator gene with sequences from non-protease region of tissue-type plasminogen activator (t-PA) and protease region of urokinase (u-PA).
    Kalyan NK; Lee SG; Cheng SM; Hartzell R; Urbano C; Hung PP
    Gene; 1988 Sep; 68(2):205-12. PubMed ID: 3146528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional effects of kringle 2 glycosylation in a hybrid plasminogen activator.
    Asselbergs FA; Bürgi R; van Oostrum J
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):27-33. PubMed ID: 8384498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.